Toll Free Helpline (India): 1800 1234 070
Rest of World: +91-9810852116
Free Publication Certificate
Submit Manuscript
Journal code(s)
- E-ISSN Number: 2277-7695
- P-ISSN Number: 2349-8242
- CODEN Code: PIHNBQ
- ZDB-Number: 2663038-2
- IC Journal ID: 7725
Main Menu
Special Issue
Copyright Form
Identifier
Vol. 10, Issue 5 (2021)
Assessment of diabetes treatment, screening and associated health care problems in a referral hospital
Author(s):
Syed Kashif Mohiuddin, Rekulapally Manju, Shirisha Cheguri, Gurram Sowmya Solomon, Gattu Devika, Nagalaksmi Gorikanti, A Pravalika and P Sathwika
Syed Kashif Mohiuddin, Rekulapally Manju, Shirisha Cheguri, Gurram Sowmya Solomon, Gattu Devika, Nagalaksmi Gorikanti, A Pravalika and P Sathwika
Abstract:
There is rapid increase in the incidence of Diabetes Mellitus (DM) in India, as in other countries. Diabetes is an autoimmune disease in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood, it also have severe long term complications like retinopathy, neuropathy, nephropathy, it also have increased evidence of cardiovascular diseases. The Glycated haemoglobin levels should be monitored for every 3 months to see if their levels are staying within range.
There is rapid increase in the incidence of Diabetes Mellitus (DM) in India, as in other countries. Diabetes is an autoimmune disease in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood, it also have severe long term complications like retinopathy, neuropathy, nephropathy, it also have increased evidence of cardiovascular diseases. The Glycated haemoglobin levels should be monitored for every 3 months to see if their levels are staying within range.
This study is a prospective observational study in which the diabetic patient was observed for symptoms, social history, medication, family history, and other clinical conditions. The study duration was of 1 year from 1st January 2020 to 1st January 2021. The evidence indicate there is increase range of HbA1C levels in majority of patients due to which chances for complications increase and only few achieve the recommended Glycemic control from the treatment. All of these issues are discussed in brief.
Pages: 395-398 | 516 Views 121 Downloads
How to cite this article:
Syed Kashif Mohiuddin, Rekulapally Manju, Shirisha Cheguri, Gurram Sowmya Solomon, Gattu Devika, Nagalaksmi Gorikanti, A Pravalika, P Sathwika. Assessment of diabetes treatment, screening and associated health care problems in a referral hospital. Pharma Innovation 2021;10(5):395-398.
Journal code(s)
- E-ISSN Number: 2277-7695
- P-ISSN Number: 2349-8242
- CODEN Code: PIHNBQ
- ZDB-Number: 2663038-2
- IC Journal ID: 7725
Main Menu
Special Issue
Copyright Form
Identifier
The Pharma Innovation Journal
